Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

UNITED THERAPEUTICS (UTHR) Invested Capital: 2009-2024

Historic Invested Capital for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to $6.7 billion.

  • UNITED THERAPEUTICS's Invested Capital rose 1.37% to $6.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 billion, marking a year-over-year increase of 1.37%. This contributed to the annual value of $6.7 billion for FY2024, which is 5.63% up from last year.
  • As of FY2024, UNITED THERAPEUTICS's Invested Capital stood at $6.7 billion, which was up 5.63% from $6.4 billion recorded in FY2023.
  • UNITED THERAPEUTICS's 5-year Invested Capital high stood at $6.7 billion for FY2024, and its period low was $3.4 billion during FY2020.
  • Over the past 3 years, UNITED THERAPEUTICS's median Invested Capital value was $6.4 billion (recorded in 2023), while the average stood at $6.0 billion.
  • Data for UNITED THERAPEUTICS's Invested Capital shows a peak YoY surged of 33.11% (in 2023) over the last 5 years.
  • UNITED THERAPEUTICS's Invested Capital (Yearly) stood at $3.4 billion in 2020, then climbed by 16.60% to $4.0 billion in 2021, then rose by 21.16% to $4.8 billion in 2022, then soared by 33.11% to $6.4 billion in 2023, then grew by 5.63% to $6.7 billion in 2024.